Haemorrhage in Association with Dextran Infusion

Abstract

Get full access to this article

View all access options for this article.

References

Adant

(1954). Influence de l'injection intravcincuse de dextran sur le fibrinogéne du plasma et de la lymphe chez le chien normal ou hepatectomisé. C. R. Soc. Biol. (Paris), 148, 391.

Adelson

(1955). The mechanism of the hemostatic defect caused by intravenous dextran. Clinical Research Proceedings, 2, 103.

Biggs

Douglas

A. S.

(1953). The measurement of prothrombin in plasma: A case of prothrombin deficiency. J. clin. Path., 6, 15.

Bull

J. P.

Ricketts

Squire

J. R.

Maycock

W. d'A.

Spooner

S. J. L.

Mollison

P. L.

Paterson

J. C. S.

(1949). Dextran as a plasma substitute. Lancet, 1, 134.

Carbone

J. V.

Furth

F. W.

Scott

Jr. Crosby

W. H.

(1954). An hemostatic defect associated with dextran infusion. Proc. Soc. Exp. Biol. & Med., 85, 101.

Fletcher

Martin

L. E.

Ratcliffe

A. H.

(1952). Interaction of macromolecules and fibrinogen. Nature (Lond.), 170, 319.

Gronwall

Ingelman

(1944). Untersuchungen über Dextran und sein Verhalten bei parenteraler Zufuhr, 1. Acta, physiol. Scand., 7, 97.

Gronwall

Ingelman

(1945). Untersuchungen über Dextran und sein Verhalten bei parenteraler Zufuhr, II. Acta, physiol. Scand., 9, 1.

Jaenicke

J. R.

Waterhouse

(1955). Metabolic and hemodynamic changes induced by the prolonged administration of dextran. Circulation, 11, 1.

10.

James

Gardillo

Metcof

F. J.

(1954). Effects of infusion of hyperoncotic dextran in children with the nephrotic syndrome. J. clin. Invest., 33, 1346.

11.

Lee

R. I.

White

P. D.

(1913). A clinical study of the coagulation time of blood. Am. J. M. Sc, 145, 495.

12.

Maycock

W. d'A

. (1952). Analysis of reports on the infusion of dextran solution. Lancet, 1, 1081.

13.

Quick

A. J.

(1935). Prothrombin in haemophilia and in obstructive jaundice. J. biol. Chem., 109, lxxiii.

14.

Ricketts

C. R.

(1952). Interaction of dextran and fibrinogen. Nature, 169, 970.

15.

Scott

J. S.

(1955). Blood coagulation failure in obstetrics. Effects of dextran and plasma. Brit. med. J., 2, 290.

16.

Squire

J. R.

(1951). Background to biological studies with dextran. Proc. R. Soc. med., 44, 557.

17.

Thorsen

(1949). Dextran as a plasma substitute. Lancet, 1, 132.

18.

Walton

(1951). Experiments with dextran sulphate as an anticoagulant. Proc. R. Soc. med., 44, 563.

19.

Walton

(1952). The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties. Brit. J. Pharmacol., 7, 370.

20.

Wilkinson

A. W.

Storey

I. D. E.

(1953). ‘Reactions’ to dextran. Lancet, 2, 956.